Executive Director
Eli Lilly & Company
Indianapolis, Indiana
Amy R. Barker, PhD
Executive Director
Eli Lilly and Company
Dr. Barker is an Executive Director at Eli Lilly and Company (Indianapolis, IN), with expertise in analytical chemistry and product commercialization. Prior to joining Lilly, she worked at PPD (Middleton, WI) in areas of both analytical development and quality control. Amy has a Ph.D in Analytical Chemistry from the University of Toledo (Toledo, OH).
Separation science, good manufacturing practice applications, and analytical methodologies have been the focus of Dr. Barker’s career in the pharmaceutical industry. Her experience ranges from method development, submissions, through sustaining analytical method lifecycle for a breadth of product formulations, methods, and technologies. She has streamlined method transfers and assisted with implementation strategies for automated technologies and rapid technologies in the quality control environment. She has co-authored multiple publications, presented internationally and externally, and serves on working groups for dissolution, biowaiver harmonization, General Chapters (USP expert committee) and the Quality Advisory Group (USP). She has also been an invited speaker to multiple venues for method transfers and analytical troubleshooting.
Disclosure information not submitted.
Streamlining Global Analytical Transfers While Maximizing Method Knowledge and Monitoring
Tuesday, July 15, 2025
1:35 PM - 2:00 PM ET